Author

Shraddha Srivastava

Institution: World Health Organization

Observed institutions: World Health Organization, Ministry of Health and Family Welfare

OpenAlex ID: A5028536224

The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019

2020 · Hye-Na Kang, Robin Thorpe, et al. · Biologicals · 63

Regulatory challenges with biosimilars: an update from 20 countries

2020 · Hye‐Na Kang, Robin Thorpe, et al. · Annals of the New York Academy of Sciences · 52

Biosimilars – status in July 2020 in 16 countries

2021 · Hye-Na Kang, Robin Thorpe, et al. · Generics and Biosimilars Initiative Journal · 5

WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25–26 June 2019

2020 · Meenu Wadhwa, Hye-Na Kang, et al. · Biologicals · 5

Works count: 4

Citation count: 125

H-index: 4

I10-index: 2